AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

BioWorld International articles

8,167 total articles

Set up an RSS feed
Close Set up an RSS feed that alerts you when new articles from BioWorld International are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds
to find out when new articles for BioWorld International arrive.

BioWorld International back issues

Recent articles from BioWorld International

Novosom in-licenses antisense CD40 inhibitors from isis pharma.
August 27, 2008... Novosom AG in-licensed from Isis Pharmaceuticals Inc. the rights to antisense inhibitors that target CD40 mRNA for several indications, including Crohn's disease, rheumatoid arthritis and organ transplant rejection. Terms were not disclosed, but Halle, Germany-based Novosom is paying...

Bacterial pneumonia, not flu, blamed in 1918 pandemic deaths.
August 27, 2008... Bacterial pneumonia and not the flu caused most of the deaths during the 1918 Spanish influenza pandemic, officials from the National Institute of Allergy and Infectious Diseases (NIAID) reported. Viral damage followed by bacterial pneumonia led to the vast majority of deaths, NIAID...

New EuropaBio chief urges more science in regulation.(Interview)
August 27, 2008... BRUSSELS, Belgium -- The new head of Europe's biggest biotech association is determined to improve the climate the industry operates in. Willy De Greef, who has just taken over as secretary general of EuropaBio, insisted the EU should deliver "top quality risk assessment informed by the best...

NicOx shares slide following goldman sachs downgrade.
August 27, 2008... PARIS -- Shares in NicOx SA have fallen by more than one-quarter on the NYSE Euronext stock exchange in Paris since the announcement by Pfizer Inc. that it was discontinuing its glaucoma collaboration with the French company. That announcement prompted Goldman Sachs to issue a sell...

F2G snares 6.3m [pounds sterling] to boost fungal-fighting compound.(Financings Roundup)
August 27, 2008... LONDON -- Antifungals specialist F2G Ltd. completed a 6.3 million [pounds sterling] (US$11.7 million) funding round, enabling it to advance development of the lead compound FG3622, a novel small molecule that is active against a number of serious fungal infections. This fourth private...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA